tiprankstipranks
Trending News
More News >
Sareum Holdings PLC (GB:SAR)
LSE:SAR

Sareum Holdings (SAR) Price & Analysis

Compare
26 Followers

SAR Stock Chart & Stats

15.00p
0.10p(0.44%)
At close: 4:00 PM EST
15.00p
0.10p(0.44%)

Sareum Holdings News

SAR FAQ

What was Sareum Holdings PLC’s price range in the past 12 months?
Sareum Holdings PLC lowest share price was 9.50p and its highest was 29.00p in the past 12 months.
    What is Sareum Holdings PLC’s market cap?
    Sareum Holdings PLC’s market cap is £20.71M.
      When is Sareum Holdings PLC’s upcoming earnings report date?
      Sareum Holdings PLC’s upcoming earnings report date is Mar 26, 2026 which is in 86 days.
        How were Sareum Holdings PLC’s earnings last quarter?
        Sareum Holdings PLC released its earnings results on Oct 23, 2025. The company reported -0.024p earnings per share for the quarter, missing the consensus estimate of N/A by -0.024p.
          Is Sareum Holdings PLC overvalued?
          According to Wall Street analysts Sareum Holdings PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Sareum Holdings PLC pay dividends?
            Sareum Holdings PLC does not currently pay dividends.
            What is Sareum Holdings PLC’s EPS estimate?
            Sareum Holdings PLC’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Sareum Holdings PLC have?
            Sareum Holdings PLC has 138,065,170 shares outstanding.
              What happened to Sareum Holdings PLC’s price movement after its last earnings report?
              Sareum Holdings PLC reported an EPS of -0.024p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 17.857%.
                Which hedge fund is a major shareholder of Sareum Holdings PLC?
                Currently, no hedge funds are holding shares in GB:SAR
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  Sareum Holdings PLC

                  Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The company was founded in 2003 and is based in Cambridge, the United Kingdom.

                  Sareum Holdings (SAR) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  ImmuPharma
                  Fusion Antibodies Plc
                  Poolbeg Pharma Ltd.
                  Arecor Therapeutics PLC
                  Aptamer Group Plc

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks